The Lung Cancer Market was valued at USD 27.5 billion in 2024 and is projected to reach USD 54.3 billion by 2034, registering a CAGR of 7.2%. This growth trajectory is underpinned by several factors, including the rising incidence of lung cancer globally, advancements in treatment modalities, and increasing awareness regarding early diagnosis and screening. According to the Global Cancer...